Corrigendum to "Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors" [Eur. Urol. Open Sci. 70 (2024) 86-90]
Eur Urol Open Sci. 2025 Jun 4:77:31.
doi: 10.1016/j.euros.2025.05.010.
eCollection 2025 Jul.
1 Translational Genomics and Targeted Therapeutics in Solid Tumours Lab, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
2 Medical Oncology Department, Hospital Clínic, Barcelona, Spain.
3 Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain.
4 Department of Medicine, University of Barcelona, Barcelona, Spain.
5 Department of Pathology, Hospital Clínic, Barcelona, Spain.
6 Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.
7 Medical Oncology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain.
8 Department of Medical Oncology, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria (INCLIVA), University of Valencia, Valencia, Spain.
9 Medical Oncology Department, Fundació Althaia, Xarxa Assistencial Universitària de Manresa, Manresa, Spain.
10 Medical Oncology Service, Instituto Valenciano de Oncología (IVO), Valencia, Spain.